Global Cytology Market 2018-2022| Growing Cervical Cancer Screening Awareness to Boost Demand| TechnavioThe Associated Press
LONDON--(BUSINESS WIRE)--Dec 7, 2018-- analysts forecast the global cytology market to grow at a CAGR of close to 7% during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181207005318/en/
Technavio has released a new market research report on the global cytology market for the period 2018-2022 (Graphic: Business Wire)
The growing popularity of co-testing is one of the major trends being witnessed in the . Human papillomavirus (HPV) is responsible for the majority of the cervical cancer cases among women. HPV+Pap testing, which is also called as co-testing is used as a screening tool for cervical cancer for improved detection of cervical intraepithelial neoplasia because it is one of the safest, cost-effective, and rapid methods. Thus, co-testing is gaining prominence, as it is more sensitive in detecting high-grade dysplasia and is likely to increase the demand for cytology testing.
This report is available at a USD 1,000 discount for a limited time only:
According to Technavio analysts, one of the key factors contributing to the growth of the global cytology market is the increasing cervical cancer screening awareness:
Global cytology market: Increasing cervical cancer screening awareness
Cervical cancer is the most common in developing as well as developed countries which are mainly caused by human papillomavirus, which makes the cytology testing for cancerous cell important. Screening of cervical cancer is mainly done by using liquid-based cytology test and pap smear test, which increases the demand for cytology testing. Also, favorable initiatives taken by the government as well as NGOs are likely to increase the awareness of cervical cancer screening and increase the volume of cytology testing market.
According to a senior analyst at Technavio, “As per CDC, in 2014, 12,578 new cervical cancer cases were diagnosed, accounting for 4,115 deaths. Also, the treatment cost accounted for USD 2 billion per year for cervical cancer in the US. Thus, many government and non-government agencies are coming forward to raise the awareness about cervical cancer and co-testing.”
Global cytology market: Segmentation analysis
The global cytology market research report provides market segmentation by end-user (hospitals and clinics, research laboratories and academic institutes, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The Americas held the largest share of the market in 2017, accounting for 46% share. It was followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the growing cervical cancer screening awareness and increasing preferences for liquid-based cytology test.
Looking for more information on this market?
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005318/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: WOMEN HEALTH ONCOLOGY OTHER HEALTH OTHER SCIENCE CONSUMER SCIENCE
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 12/07/2018 10:34 AM/DISC: 12/07/2018 10:33 AM